India's first dengue vaccine, expected to launch in 2026 after local trials; WHO-approved jab offers two-dose protection ...

GSK posted higher profit as sales for its specialty treatments for HIV, cancer and asthma beat expectations, offsetting lower ...

"We know it's safe and effective," said Spencer. The latest numbers from the CDC suggest some people are still refusing to get the vaccine. As of Friday, 29 states have reported 884 confirmed measles ...